SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549

                            FORM 10-C

         REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
                  INTERDEALER QUOTATION SYSTEM
                                
          Filed pursuant to Section 13 or 15(d) of the
         Securities Exchange Act of 1934 and Rule 13a-17
                      or 15d-17 thereunder


                      Quality Systems, Inc.                      
         (Exact name of issuer as specified in charter)

   17822 E. 17th Street, Suite 210, Tustin, California  92680    
            (Address of principal executive offices)

Issuer's telephone number, including area code    (714) 731-7171 


           I.  CHANGE IN NUMBER OF SHARES OUTSTANDING

Indicate any change (increase or decrease) of five percent or
more in the number of shares outstanding:
1.   Title of security   Common stock, par value $.01 per share  
2.   Number of shares outstanding before the change    5,653,491 
3.   Number of shares outstanding after the change     5,963,337 
4.   Effective date of change      May 17, 1996                  
5.   Method of change: 

          Specify method (such as merger, acquisition, exchange,
          distribution, stock split, reverse split, acquisition
          of stock for treasury, etc.)

                             Merger                              

Give brief description of transaction  

Merger of a Clinitec International, Inc. ("Clinitec"), with and
into CII Acquisition Corporation, a wholly-owned subsidiary of
Quality Systems, Inc. ("QSI"), pursuant to which the shareholders
of Clinitec will receive an aggregate of 309,846 shares of QSI
Common Stock and cash consideration.










                  II.  CHANGE IN NAME OF ISSUER

1.   Name prior to change     N/A                                
2.   Name after change   N/A                                     
3.   Effective date of charter amendment changing name      N/A  
4.   Date of shareholder approval of change, if required    N/A  


                                    
Date      May 30, 1996                 /s/ Robert McGraw, Chief                                                  
                                           Financial Officer
                                        (Officer's signature and title)